SCHEMBL6512663

SCHEMBL6512663

CC1(C)CC(C)(C)CC(C)(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 1/20 0.38
APLNR P35414 1/20 0.34
RORC P51449 1/20 0.34
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HCRTR2 O43614 1/20 0.33
BTK Q06187 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
DGAT1 O75907 1/20 0.32
CTSL P07711 1/20 0.32
CTSK P43235 1/20 0.32
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2087734 0.82 RORC (0.43) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL21503947 0.80 MEN1 (0.36) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL3076558 0.79 TSHR (0.34) GAA
SCHEMBL18424709 0.78 RORC (0.39) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL17520236 0.78 RORC (0.39) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL26527194 0.78 MEN1 (0.34) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL24572117 0.77 RORC (0.39) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL13423612 0.77 KMT2A (0.38) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL3315842 0.77 MEN1 (0.41) GAAMEN1KMT2AMAPK1APLNR
SCHEMBL26018305 0.77 RORC (0.39) GAAMEN1KMT2AMAPK1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556019-A2 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS Merz Pharma GmbH & Co. KGaA (DE) 2005-07-27 EP disclosed
WO-2004037234-A2 COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS MERZ PHARMA GMBH & CO. KGAA (DE) 2004-05-06 WO disclosed